Heart Failure V: Medical Management
Heart Failure Drugs: Diuretics
Heart Failure VI: Adjunct Therapies
Heart Failure III: Clinical Manifestations
Heart Failure Drugs: Inotropic Agents
Heart Failure IV: Classification and Diagnostic Evaluation
Paul W Armstrong1, Carolyn S P Lam2, Kevin J Anstrom3
1Division of Cardiology, Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada.

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
Published on: April 8, 2013
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
在PubMed 上查看摘要
在心力衰竭患者中,Vericiguat没有改善心力衰竭患者的身体限制. 这项研究评估了
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: